Table 1.
Country | Society | Title | Language | Date | Ref |
---|---|---|---|---|---|
France |
Bone Task Force of the French Society for rheumatology (SFR) and of the Osteoporosis Research and Information Group (GRIO), |
2018 update of French recommendations on the management of postmenopausal osteoporosis | English | 2018 | [13] |
Germany | Dachverband Osteologie | Prophylaxe, Diagnostik und Therapie der Osteoporose (in German/English) | German/ English | 2023 | [14, 24] |
Italy | Sistema Nazionale per le Linee Guida | Diagnosi, stratificazione del rischio e continuità assistenziale delle fratture da fragilità 2021 (in Italian) | Italian | 2021 | [33] |
Sistema Nazionale per le Linee Guida | Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021 | English | 2023 | [20] | |
Inter-Society Commission for Osteoporosis | Guidelines for the management of osteoporosis and fragility fractures | English | 2019 | [15] | |
Spain | Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM) | Clinical practice guideline of postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update | English | 2022 | [16, 17] |
UK | National Institute for Health and Care Excellence | Clinical Guideline CG146 Osteoporosis: assessing the risk of fragility fracturea | English | 2012, last updated 2017 | [5] |
National Institute for Health and Care Excellence | Guideline NG23 menopause: diagnosis and management | English | 2015, last updated 2019 | [34] | |
National Institute for Health and Care Excellence | Clinical knowledge summary osteoporosis—prevention of fragility fractures | English | 2023 | [2] | |
National Osteoporosis Guideline Group (NOGG) UK | Clinical guideline for the prevention and treatment of osteoporosis | English | 2021 | [6] |
aNICE is currently developing updated guidance for osteoporosis risk assessment, treatment and fragility fracture prevention, to be delivered by 2025[11]